Hologic Inc
Hologic Inc Fundamental Analysis
Hologic Inc (HO1.DE) shows weak financial fundamentals with a PE ratio of 39.37, profit margin of 12.42%, and ROE of 7.99%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 57.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze HO1.DE's fundamental strength across five key dimensions:
Efficiency Score
WeakHO1.DE struggles to generate sufficient returns from assets.
Valuation Score
ModerateHO1.DE shows balanced valuation metrics.
Growth Score
ModerateHO1.DE shows steady but slowing expansion.
Financial Health Score
ExcellentHO1.DE maintains a strong and stable balance sheet.
Profitability Score
WeakHO1.DE struggles to sustain strong margins.
Key Financial Metrics
Is HO1.DE Expensive or Cheap?
P/E Ratio
HO1.DE trades at 39.37 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, HO1.DE's PEG of -10.46 indicates potential undervaluation.
Price to Book
The market values Hologic Inc at 3.36 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -1.01 times EBITDA. This is generally considered low.
How Well Does HO1.DE Make Money?
Net Profit Margin
For every $100 in sales, Hologic Inc keeps $12.42 as profit after all expenses.
Operating Margin
Core operations generate 23.26 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.99 in profit for every $100 of shareholder equity.
ROA
Hologic Inc generates $4.69 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $2.40 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
39.37
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-10.46
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.36
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.52
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How HO1.DE Stacks Against Its Sector Peers
| Metric | HO1.DE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 39.37 | 28.03 | Worse (Expensive) |
| ROE | 7.99% | 734.00% | Weak |
| Net Margin | 12.42% | -46943.00% (disorted) | Strong |
| Debt/Equity | 0.52 | 0.35 | Weak (High Leverage) |
| Current Ratio | 3.55 | 2778.18 | Strong Liquidity |
| ROA | 4.69% | -17472.00% (disorted) | Weak |
HO1.DE outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Hologic Inc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation